drugset / Trial / NCT07177872
A Long-term Efficacy and Safety of NTQ5082 Capsules
NaSingle-groupOpen-labelTreatment
Summary
NTQ5082 capsules are a small molecule CFB inhibitor. This study is a multicenter, open-label study evaluating the long-term efficacy and safety of NTQ5082 capsules in the treatment of patients with paroxysmal nocturnal hemoglobinuria
Timeline
- Start
- 2026-06
- Primary completion
- 2028-06
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NTQ5082 | Small molecule | 200 mg | — |